TickerFactsScreenerDevelopers

Karyopharm Therapeutics Inc. (KPTI) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$10.31M2012: -$15.89M2013: -$33.95M2014: -$75.85M2015: -$119.08M2016: -$110.73M2017: -$130.54M2018: -$179.88M2019: -$189.28M2020: -$171.85M2021: -$98.27M2022: -$142.20M2023: -$129.54M2024: -$119.44M2025: -$90.71M-$90.71M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$90.71M+24.1%
2024-$119.44M+7.8%
2023-$129.54M+8.9%
2022-$142.20M-44.7%
2021-$98.27M+42.8%
2020-$171.85M+9.2%
2019-$189.28M-5.2%
2018-$179.88M-37.8%
2017-$130.54M-17.9%
2016-$110.73M+7.0%
2015-$119.08M-57.0%
2014-$75.85M-123.4%
2013-$33.95M-113.7%
2012-$15.89M-54.1%
2011-$10.31M—